Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 381-399)

Mrs Sue Hattersley, Miss Gill Fine, Ms Andrea Martinez-Inchausti, Dr Ian Leitch and Mr Les Bailey

31 JANUARY 2007

  Q381Chairman: Good morning and thank you for coming. Can I welcome those of you who are giving evidence to us today and also members of the public who have come to listen in on this session. This is the sixth hearing of our inquiry into allergy. There is an information note of the declared interests of members of the Committee so we will not be repeating those today during our evidence session. I would like to ask those of you who are here to start off by giving us a short introduction with your name and where you are from. I also remind you that this session is being webcast today, so it is being broadcast. Could I invite you to start, Mr Bailey.

  Mr Bailey: I am Les Bailey from the Local Authorities Coordinators of Regulatory Services. We are the central local government body that acts to try to co-ordinate the activities of local authority environmental health and trading standards departments. I deal with food standards, food composition and food labelling issues, which includes allergens. My previous background is in trading standards.

  Dr Leitch: I am Ian Leitch. I come from an environmental health background from Omagh District Council. I am presently project manager for a food allergy project to train environmental health officers in food allergen control. That is sponsored by Safefood which is the Ireland food safety body and by the EU through a programme called CAWT which stands for Co-operation and Working Together and it is for training in the border regions. I come from an environmental health background with a particular interest in allergen control.

  Ms Martinez-Inchausti: My name is Andrea Martinez-Inchausti and I represent the retailers. I am here representing the British Retail Consortium which is the trade association that represents retailers to both governmental and non-governmental bodies. I work as the Assistant Director of Food Policy and I deal with the majority of the technical legislative issues. My background is veterinarian.

  Miss Fine: My name is Gill Fine. I am Director of Consumer Choice and Dietary Health at the Food Standards Agency. The Agency was set up in 2000 to protect the health of the public in relation to food and drink and also to reflect their interests. I head up a group of three divisions, one of which covers food allergy as part of its remit. My background is as a nutritionist.

  Mrs Hattersley: I am Sue Hattersley. I am also from the Food Standards Agency. I head up the Allergy and Intolerance Branch within the Agency so I have the overall responsibility for that area of work.

  Q382  Chairman: Could I start of by asking you as a panel whether there is any evidence that there may be a link between changes in the modern diet and an increase in the incidence of asthma and allergy? Would you like to start, Mrs Hattersley?

  Mrs Hattersley: There is evidence that the prevalence of different food allergies does vary in different countries, depending on dietary practices. We know that weaning practices have changed very significantly in the UK over the last 50 years. There is evidence that different weaning practices across different countries might lead to different incidence of food allergy. If you look for instance, at Jewish children in the UK, there is a very different incidence of peanut allergy in that group compared to Jewish children in Israel, where they use a peanut snack as a weaning food. There are very clear dietary differences in different countries. We also know that the introduction of new foods into the diet can lead to new allergies and we have done some research on kiwi which is an emerging allergen in the UK. We also know that cooking practices can change the allergenicity of certain foods. Roasted peanut, for example, is much more allergenic that raw peanut, but cooked egg is less allergenic than raw egg.

  Ms Martinez-Inchausti: I would agree with what Sue has said. What has also triggered an increased amount of allergies has been the increase of awareness both by paediatricians or practitioners and consumers, and the development of methods to diagnose those allergies has also triggered an increase in the numbers.

  Q383  Chairman: I wonder whether there is any evidence that sulphites and preservatives, possibly even including things like trans fats in pre-packaged foods affect allergy sufferers, and in which foods are they found?

  Mrs Hattersley: We know that sulphites can trigger asthma attacks in people who already have asthma and that is why sulphites are included on the list of allergens that have to be declared in pre-packed foods. If sulphites are added to foods that now has to be labelled so that people can avoid those foods.

  Q384  Chairman: Could foods be modified to remove such substances from them so that we would remove the substances potentially contributing to allergic disorders?

  Mrs Hattersley: It is very difficult. There has been some work done to look to see whether they could remove some of the allergenic proteins from peanuts but we know that there is not just one protein in the peanut, there are perhaps half a dozen different allergenic proteins. If you try to breed a peanut that has less of one protein it may be producing more of the other proteins and very often in the nuts and seeds it is the storage proteins which are allergenic so there tends to be very high levels of those proteins in the foods.

  Q385  Lord Taverne: What research is the FSA supporting to identify the characteristics of foods which can lead to the development of food allergy and intolerance?

  Mrs Hattersley: We know that most food allergens are proteins so we have done some research to look at the characteristics of proteins that make them allergenic and there are certain characteristics which tend to be associated with allergenic proteins. They tend to be resistant to digestion; they tend to be present in very large amounts; they tend to have multiple binding sites for the IgE antibodies. Some non-allergenic proteins also have very similar characteristics so we think there are other factors involved as well. Other molecules attaching to the protein affect the allergenicity as well, so it is still an area of on-going research.

  Q386  Lord Taverne: I gather that some of your research has been into early life exposure and pregnancy exposure which suggests that low level environmental exposure to allergens can actually lead to sensitisation, rather the opposite, as it were, of some early exposure leading to immunity which we found with farm animals and possibly with peanuts.

  Mrs Hattersley: There is certainly some evidence indicating that low level environmental exposure to some of the allergens, particularly peanut, may cause sensitisation, whereas if you have higher dose oral exposure then that may lead to tolerance. This is the evidence that we are getting from the study of Jewish children in Israel, where they use the peanut snack as a weaning food. It found that if you have a high level oral exposure that actually leads to the development of tolerance, whereas if you have just a very low level exposure—sometimes dermal exposure—that may be leading to sensitisation.

  Q387  Lord Taverne: Dermal exposure to peanuts?

  Mrs Hattersley: Yes. We know that peanut oil used to be used in creams for eczema. Also a lot of natural cosmetic and toiletry products have nut oils in them, so that may be another route of exposure. Also, if other people in the household are eating peanuts then there may be peanuts on people's hands and it is in the general environment so that may be leading to sensitisation at those very low levels.

  Q388  Lord Taverne: What about the effect of latex-containing packaging? Is that possibly something which could trigger dermatitis or exacerbate it?

  Mrs Hattersley: We know that there is an increase in latex allergy in healthcare workers, for example, who wear a lot of latex gloves. There is also work being done to look at latex allergy in food handlers because some food handlers wear gloves. The Agency has done some research to try to develop a methodology for looking at levels of latex in packaging materials, to see whether that transfers into the food. At the moment we are starting to develop that methodology and there is a further project underway at the moment trying to develop that further so that we have a reliable test to see how much latex might be getting into the food.

  Q389  Lord Taverne: What is your method of dealing with proposals for research into allergy? Do you take unsolicited proposals or do you only support contract studies?

  Mrs Hattersley: Normally we issue open calls for research proposals, the Agency will do that on a regular basis. Three or four times a year we will issue calls for proposals, which may include calls on food allergy. People submit their proposals and they are independently appraised before we contract any research. People can also come to us if they have particular research ideas. One of the examples was the work that we did on kiwi allergy. Somebody came to us asking whether they could do a pilot study to look at the characteristics of kiwi allergy and we funded that. Then we funded further study into it because it looked like there was an issue there. It can be via either route.

  Q390  Earl of Selborne: Still on the subject of research funding for proposals, there must be a lot of international work in this field and I wonder whether the FSA is confident that it can keep in track with other relevant research in other countries, particularly for example with something like the kiwi fruit you have just referred to. Presumably one would go to South Africa or New Zealand or somewhere to look at some of the work on relevant populations.

  Mrs Hattersley: In running our programme we have an independent adviser who is an expert in the allergy field so he helps us to keep up to date with the literature. We also scan the literature ourselves to see what work is being done elsewhere. As I said, when we call for proposals for new research we do have them independently appraised by external experts, so again it is bringing their expertise in to look at the work people propose to do so that we make sure we do not duplicate work that has already been done elsewhere.

  Q391  Viscount Simon: You mentioned IgE. In your submissions in the T07 research programme you put IgG. I wonder if you could explain the difference and why it is included in your research programme.

  Mrs Hattersley: The IgE response is typical of the allergic reaction, in that you are producing those particular types of immunoglobulin proteins in response to the challenge with the allergen, but it is not just the specific IgE that is produced in response to, say, peanut or egg that seems to be relevant to the level of response seen in an individual. We think that IgG may help moderate that response but it remains unclear how, and certainly there are what are called T regulatory cells which are particular types of lymphocytes which also help moderate the immune response. It is a matter of looking at how that response is triggered and all the other factors that might moderate it. Both the IgG and the regulatory cells seem to be implicated in the development of tolerance and we are trying to do some research to see why it is that some people outgrow their allergies (egg and milk allergies are often outgrown by the time the child is five) and so if we can understand how that tolerance develops then we might be able to do something to moderate the types of reactions that happen.

  Q392  Chairman: What is the research budget for food allergy research in the UK?

  Miss Fine: The research budget for the allergy work is around £1 million each year and that represents about five per cent of the Agency's research budget. I should add, in response to the work on the international side, we are very keen that we get the best value for money from the research, so increasingly we are looking to see how we can work collaboratively with activities that are happening in Europe and internationally.

  Q393  Viscount Simon: Is £1 million a year enough?

  Miss Fine: Research is quite a hungry beast and the Agency funds research across a wide range of food issues. We are very keen that we carry on with the research in this area. £1 million is a significant amount but whether it is ever enough I think is very hard to say.

  Q394  Chairman: How does that compare to the US or European budgets, do you know?

  Mrs Hattersley: I am not sure about the budgets in the US but we are part of a very large EU framework programme which I think has about £12.5 million worth of research looking at the prevalence of food allergy and it is also looking at things like the food matrix and whether the type of food that the allergen is in makes a difference. They are also looking at quality of life issues. We are collaborating with them but by funding one particular arm of the study in the UK we have access to all that information so the collaborative research is a very good way of making our money go further.

  Q395  Lord Colwyn: I am aware that the UK has been pressing for improved labelling of allergenic ingredients in food. How do current labelling regulations recognise allergens in foods? Who decides at what level an allergen must be listed? We have a list from the FSA here and I notice, for instance, that kiwi fruit is not even included.

  Miss Fine: The current regulations require declaration of ingredients when they have been deliberately added and there is no threshold for that. If a manufacturer or retailer is using a food or ingredient that contains these allergens it must be declared on the label. The way in which that list is determined is that, because labelling is an EU competency, the European Commission asks the European Food Safety Authority for advice on which of the allergens are of public health concern across all Member States and that is where the initial list of 12 allergens came from. Subsequently there have been another two added in December last year. I think the key thing here is that it has helped to improve the clarity of the label for consumers so whereas before it would say "casein" in the ingredients it now says "casein from milk" so it helps the consumer understand more clearly where those particular allergens are coming from.

  Q396  Lord Colwyn: What are the other two that have been added?

  Miss Fine: Molluscs and lupins have been added to the list. There will be a period of time before which the manufacturers and retailers have to declare it but they have now been added to the list.

  Q397  Lord Colwyn: Obviously sensitivity levels for allergens vary amongst individuals. Would it be a good idea to define a level above which the packaging must list any particular allergen?

  Mrs Hattersley: The legislation for the pre-packed food is that the allergen has to be labelled regardless of the level of addition, if it is deliberately added as an ingredient. The science at the moment is not yet able to let us set thresholds for the allergens in food. We have guidance on the advisory labelling to cover possible cross-contamination but at the moment we do not really have enough evidence to set even the clinical thresholds for the allergens (below which an individual would not react). As you say, individuals vary very considerably in their response, so it is how you would turn that information into a management level that the industry could use. We do not yet have the scientific evidence to be able to do that but we are actually working with this European consortium that we mentioned earlier and are holding a conference this summer to look at that whole question of how you actually set the threshold levels for the food because you have to work out the safety factors that you need to include in those calculations to protect the most sensitive individuals. Risk assessment in that way is fairly well established for chemicals, for toxicological evaluations, but no-one has yet tried to apply that to allergens so this conference is going to be pulling together experts from around the world so there will be European and American experts there to help us discuss how you actually do that risk assessment. It is something that is in progress and we know it is something that does need to be done.

  Q398  Lord Colwyn: You refer to "we"; that means the FSA does it?

  Mrs Hattersley: Yes[17]

  Q399Lord Colwyn: Who else is researching these threshold levels?

  Mrs Hattersley: Academics are doing research in that area and certainly other government authorities are doing work as well.



17   Guidance on Allergen Management and Consumer Information ("May Contain" Labels)-We should also like to clarify that "May Contain" was produced by the Food Standards Agency, working in collaboration with stakeholders, including the Food and Drink Federation and the British Retail Consortium. We are grateful to them for producing the first draft of the document, which was based on their own previous guidance. Back


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries index

© Parliamentary copyright 2007